What does Rydex Biotechnology Inv do?

Rydex Biotechnology Inv (RYOIX) operates in the Asset Management industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.

What is RYOIX's market cap?

Rydex Biotechnology Inv (RYOIX) has a market capitalization of approximately $92.3 million, as of July 23, 2026, based on the most recent share price and shares outstanding.

Does RYOIX pay a dividend?

Yes — Rydex Biotechnology Inv (RYOIX) pays a dividend annually, with a trailing-twelve-month yield of 10.75%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.

RYOIX

Rydex Biotechnology Inv

NASDAQ·Asset Management · Financial Services

$87.48$0.90−1.02%

Market cap$92.31M·Jul 23 12:10 PM UTC

Price Chart

$87.48−$0.90 (−1.02%)today

−14.73%CAGR −3.14%

Select date range

FromTo

Mar 31, 1998Jul 23, 2021 → Jul 23, 2026· 5.0 yrsJul 23, 2026

Key Metrics

DividendDividend Tab

Dividend Yield (FWD)10.75%

Annual Dividend (FWD)$9.41

Dividend Growth (5Y)+6.2%

Dividend Safety—

Payout Ratio—

FCF Payout Ratio—

Most Recent Dividend$9.41

Ex-Dividend DateDec 16

Payment DateDec 16

EarningsEarnings Tab

EPS (FWD)—

P/E Ratio (FWD)—

EPS Growth (1Y)—

EPS Growth (3Y)—

EPS Growth (5Y)—

Next Earnings Date—

Last Report Date—

Reported vs Estimate—

Earnings Surprise—

Income Statement Flow

PRO

See exactly how RYOIX's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.

The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for RYOIX and 80,000+ other tickers.

About Rydex Biotechnology Inv

Under normal circumstances, the fund invests substantially all (at least 80%) of its net assets in equity securities of Biotechnology Companies that are traded in the United States and in derivatives, which primarily consist of futures contracts and options on securities, futures contracts, and stock indices. It may invest to a significant extent in the securities of Biotechnology Companies that have small to mid-sized capitalizations. The fund is non-diversified.

Sector: Financial Services
Industry: Asset Management
Exchange: NASDAQ
Website: www.royceinvest.com

Peers

Janus Henderson Small-Mid Cap Value Fund - T Shares

Cap

$71.5M

ETNEX

Eventide Exponential Technologies Fund Class N

Cap

$105.8M

Latest News

News Tab

No recent news available.

Frequently Asked Questions About RYOIX

What does Rydex Biotechnology Inv do?: Rydex Biotechnology Inv (RYOIX) operates in the Asset Management industry within the Financial Services sector. Full company description, peers, and segment breakdown are on the page above.
What is RYOIX's market cap?: Rydex Biotechnology Inv (RYOIX) has a market capitalization of approximately $92.3 million, as of July 23, 2026, based on the most recent share price and shares outstanding.
Does RYOIX pay a dividend?: Yes — Rydex Biotechnology Inv (RYOIX) pays a dividend annually, with a trailing-twelve-month yield of 10.75%. Full distribution history, payout ratios, and growth rates are on the Dividend tab.